Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bastard JP et al. – Several recent studies have shown the importance of this macrophagic infiltration in obesity and much work is underway to improve the understanding of its role in the physiopathology of cardiovascular complications related to obesity, the metabolic syndrome and type 2 diabetes.

Related Articles

Obesity, intentional weight loss and physical disability in older adults
Obesity Reviews, 11/18/09    Relevance Score: 94%

Early life influences on obesity risk: maternal overnutrition and programming of obesity
Expert Review of Endocrinology & Metabolism, 11/12/09    Relevance Score: 94%

Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
Amylin Pharmaceuticals, 10/20/09    Relevance Score: 94%

Obesity as a disease state: A new paradigm for diagnosis and treatment
Clinical Cornerstone, 10/21/09    Relevance Score: 93%

Obesity as a Social Problem in the United States
Policy, Politics, & Nursing Practice, 10/01/09    Relevance Score: 93%

Today in Obesity...keeping you current

Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight
International Journal of Obesity, 11/25/09

The prognostic impact of general and abdominal obesity in peripheral arterial disease
International Journal of Obesity, 11/25/09

Low Levels of Plasma Agmatine in the Metabolic Syndrome
Metabolic Syndrome and Related Disorders, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address